CIAM
ALLR

Caitong International Asset Management’s Allarity Therapeutics ALLR Stock Holding History

Caitong International Asset Management’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28 Buy
22
+21
+2,100% +$30 ﹤0.01% 2449
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2458

Other funds holding ALLR

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Caitong International Asset Management's ALLR Position: Q2 2026 in Review

Caitong International Asset Management increased its Allarity Therapeutics (ALLR) stake by 2,100% in Q2 2026, buying an estimated $30 and bringing the position to 22 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Caitong International Asset Management first reported a position in ALLR in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Caitong International Asset Management held 22 shares of Allarity Therapeutics worth $28 as of Q2 2026.
  • Caitong International Asset Management bought 21 Allarity Therapeutics shares in Q2 2026, an estimated $30.
  • Allarity Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2449 holding.
  • Caitong International Asset Management first reported a position in Allarity Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.